Skip to main content

Table 1 Study population characteristics

From: Determinants of prehospital lactate in trauma patients: a retrospective cohort study

 

All (n = 156)

Lactate < 2.5 mmol/L (n = 61)

Lactate > 2.5 mmol/L (n = 95)

p

missing

Biometric data

 Age (y)

44 [24–64]

44 [23–66]

45 [27–63]

.642

 

 Male Gender (n,%)

124 [79.5]

48 [78.7]

76 [80]

.842

 

Injury characteristics

 Mechanism

  Blunt trauma (n,%)

140 [89.7]

56 [91.8]

84 [88.4]

.595

 

  Sharp trauma (n,%)

16 [10.3]

5 [8.2]

11 [11.6]

.595

 

 Body regions affected

  Head (n,%)

84 [53.8]

25 [41.0]

59 [62.1]

.008

2

  Chest (n,%)

73 [46.8]

31 [50.8]

42 [45.2]

.513

2

  Abdomen (n,%)

72 [46.2]

29 [47.5]

43 [45.3]

.870

 

  Limb (n,%)

75 [48.1]

29 [47.5]

46 [48.4]

.990

 

 Nr of regions affected (n)

2 [0–4]

2 [0–4]

2 [0–4]

.373

 

Lactate

 999-lactate sample (min)

66 [46–87]

62 [45–80]

67 [46–88]

.420

33

 Lactate (mmol/l)

3.0 [2.0–4.1]

1.8 [0.5–2.2]

3.8 [2.7–4.9]

<.001

 

Indices of end organ perfusion and oxygenation

 Palpable radial pulse [y]

138 [88.5]

58 [95.1]

80 [84.2]

.042

 

 SBP (mmHg)

129 [109–149]

134 [117–152]

123 [102–144]

.001

10

 HR (bpm)

88 [66–110]

85 [64–106]

96 [75–117]

.023

14

 Shock index

.72 [.51–.93]

.61 [.40–.82]

.80 [.58–1.03]

<.001

14

 EtCO2 (kPa)

4.1 [3.5–5.4]

4.1 [2.0–6.0]

4.0 [3.2–4.8]

.390

44

 SpO2 (%)

97 [93–100]

98 [96–100]

96 [89–100]

.025

16

Treatments before HEMS

 Circ and resp. support

  Adrenaline

6 [3.8]

1 [1.6]

5 [5.3]

.405

 

  IV fluids

14 [9.0]

2 [3.3]

12 [12.6]

.050

 

 Pain relieving interventions

  IVP and/or morphine

87 [55.8]

41 [67.2]

49 [51.6]

.031

 

   IVP

61 [39.1]

30 [49.2]

31 [32.6]

.045

 

   morphine

51 [32.7]

23 [37.7]

28 [29.5]

.299

 

  Reduction or splintinga

29 [18.6]

8 [13.1]

21 [22.1]

.207

 

 Haemostatic interventions

  Pelvic splint

76 [48.7]

28 [45.9]

48 [50.5]

.624

 

  Compression Bandage or tourniquet

14 [9.0]

7 [11.5]

7 [7.4]

.402

 

  TXA

75 [48.1]

26 [42.6]

49 [51.6]

.325

 
  1. Footnote: Continuous data represented as n [%], nominal data as median [IQR]. amanual reduction of fracture or dislocation and/or Kendrick and/or vacuum splint application. SBP Systolic blood pressure, HR Heart rate, EtCO2 End tidal CO2, SpO2 Percentage oxygen saturation, IV Intravenous, IVP Intravenous paracetamol, TXA Tranexamic acid.